๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis

โœ Scribed by Boumpas, D.T.; Austin, H.A.; Balow, J.E.; Vaughan, E.M.; Yarboro, C.H.; Klippel, J.H.; Steinberg, A.D.

Book ID
120803277
Publisher
The Lancet
Year
1992
Tongue
English
Weight
653 KB
Volume
340
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Randomized controlled trial of pulse/syn
Randomized controlled trial of pulse/synchronization cyclophosphamide/apheresis for proliferative lupus nephritis
โœ Daniel J. Wallace; Dennis Goldfinger; Samuel H. Pepkowitz; Marshal Fichman; Alla ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 39 KB ๐Ÿ‘ 1 views

OBJECTIVE: To assess the efficacy of pulse/synchronization cyclophosphamide/apheresis in patients with proliferative lupus nephritis. METHODS: Eighteen patients with Class III or IV renal biopsies and chronicity indices <6 were prospectively randomized to receive 6 courses of parenteral cyclophospha

Plasmapheresis and subsequent pulse cycl
Plasmapheresis and subsequent pulse cyclophosphamide versus pulse cyclophosphamide alone in severe lupus: Design of the LPSG trial
โœ William F. Clark; Peter C. Dau; Hans H. Euler; Loรฏc Guillevin; Joerg Hasford; An ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 749 KB

A group of clinics are collaborating in the Lupus Plasmapheresis Study Group (LPSG) to investigate whether repeated plasmapheresis prior to pulse cyclophosphamide improves the therapeutical results in severe systemic lupus erythematosus (SLE). The underlying rationale is the hypothesis that plasmaph